TY - JOUR
T1 - Clinical practice guidelines by the infectious diseases society of America (IDSA), American academy of neurology (AAN), and american college of rheumatology (acr)
T2 - 2020 guidelines for the prevention, diagnosis and treatment of lyme disease
AU - Lantos, Paul M.
AU - Rumbaugh, Jeffrey
AU - Bockenstedt, Linda K.
AU - Falck-Ytter, Yngve T.
AU - Aguero-Rosenfeld, Maria E.
AU - Auwaerter, Paul G.
AU - Baldwin, Kelly
AU - Bannuru, Raveendhara R.
AU - Belani, Kiran K.
AU - Bowie, William R.
AU - Branda, John A.
AU - Clifford, David B.
AU - Dimario, Francis J.
AU - Halperin, John J.
AU - Krause, Peter J.
AU - Lavergne, Valery
AU - Liang, Matthew H.
AU - Meissner, H. Cody
AU - Nigrovic, Lise E.
AU - Nocton, James J.
AU - Osani, Mikala C.
AU - Pruitt, Amy A.
AU - Rips, Jane
AU - Rosenfeld, Lynda E.
AU - Savoy, Margot L.
AU - Sood, Sunil K.
AU - Steere, Allen C.
AU - Strle, Franc
AU - Sundel, Robert
AU - Tsao, Jean
AU - Vaysbrot, Elizaveta E.
AU - Wormser, Gary P.
AU - Zemel, Lawrence S.
N1 - Publisher Copyright:
© 2020 The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: [email protected].
PY - 2021/1/1
Y1 - 2021/1/1
N2 - This evidence-based clinical practice guideline for the prevention, diagnosis, and treatment of Lyme disease was developed by a multidisciplinary panel representing the Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR). The scope of this guideline includes prevention of Lyme disease, and the diagnosis and treatment of Lyme disease presenting as erythema migrans, Lyme disease complicated by neurologic, cardiac, and rheumatologic manifestations, Eurasian manifestations of Lyme disease, and Lyme disease complicated by coinfection with other tick-borne pathogens. This guideline does not include comprehensive recommendations for babesiosis and tick-borne rickettsial infections, which are published in separate guidelines. The target audience for this guideline includes primary care physicians and specialists caring for this condition such as infectious diseases specialists, emergency physicians, internists, pediatricians, family physicians, neurologists, rheumatologists, cardiologists and dermatologists in North America.
AB - This evidence-based clinical practice guideline for the prevention, diagnosis, and treatment of Lyme disease was developed by a multidisciplinary panel representing the Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR). The scope of this guideline includes prevention of Lyme disease, and the diagnosis and treatment of Lyme disease presenting as erythema migrans, Lyme disease complicated by neurologic, cardiac, and rheumatologic manifestations, Eurasian manifestations of Lyme disease, and Lyme disease complicated by coinfection with other tick-borne pathogens. This guideline does not include comprehensive recommendations for babesiosis and tick-borne rickettsial infections, which are published in separate guidelines. The target audience for this guideline includes primary care physicians and specialists caring for this condition such as infectious diseases specialists, emergency physicians, internists, pediatricians, family physicians, neurologists, rheumatologists, cardiologists and dermatologists in North America.
UR - http://www.scopus.com/inward/record.url?scp=85100324388&partnerID=8YFLogxK
U2 - 10.1093/cid/ciab049
DO - 10.1093/cid/ciab049
M3 - Article
C2 - 33417672
AN - SCOPUS:85100324388
SN - 1058-4838
VL - 72
SP - 1
EP - 8
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 1
ER -